NCT04302285

Brief Summary

The study applied a randomized, crossover design with preliminary (screening) session and two sequenced experimental trials. Trials were marked as Control trial and Exercise trial. Participants were asked to either resting (Control trial) or exercising (Exercise trial) for one hour. In the two trials, appetite questionnaires were obtained, blood samples were collected, and metabolic rates were measured every 30 minutes. Participants in both trials were presented to a standard isocaloric PKU type meal at 120 min. After the completion of the last measurement, the participants were presented with an ad libitum buffet test meal at 300 min. Participants required to record their EI for the remainder of the experimental day using a self-recorded food diary. Two days prior the experimental trials participants refrained from exercise and alcohol intake. All data collection took place in the metabolic research unit at New Lister Building, Glasgow Royal Infirmary.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 3, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 10, 2020

Completed
Last Updated

March 10, 2020

Status Verified

March 1, 2020

Enrollment Period

1 year

First QC Date

February 4, 2020

Last Update Submit

March 9, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Peptide YY (PYY)

    Changes in plasma concentration of fasting and postprandial PYY were measured during the Exercise and Control trials.

    300 minutes through study completion, an average of 12 days

  • Glucagon-like peptide-1 (GLP-1)

    Changes in plasma concentration of fasting and postprandial GLP-1 were measured during the Exercise and Control trials.

    300 minutes through study completion, an average of 12 days

Secondary Outcomes (5)

  • Subjective appetite score

    300 minutes through study completion, an average of 12 days

  • Dietary intake

    24 hours through study completion, an average of 12 days

  • Diet induced thermogenesis

    300 minutes through study completion, an average of 12 days

  • Growth differentiation factor 15 (GDF-15)

    300 minutes through study completion, an average of 12 days

  • Fat oxidation

    300 minutes through study completion, an average of 12 days

Study Arms (2)

Exercise trial

EXPERIMENTAL

In this trial, participants were asked to exercise for one hour under controlled laboratory conditions. Participants were exercising on the treadmill at speed and grade corresponding to 60% of their V̇O2max. Participants were wearing a HR monitor and a face mask while exercising, connected to indirect calorimetry equipment. Appetite questionnaires were obtained, and blood samples were collected at 30, 60, 90 and 120 pre-meal, 150, 180, 210, 240 and 300 min post-meal. Metabolic rate was measured every 30 min after each blood sample. Participants were presented to a standard isocaloric PKU type meal at 120 min. After the completion of the last measurement, the participants were presented with an ad libitum buffet test meal.

Other: PKU type meal and Exercise

Control trial

EXPERIMENTAL

In this trial, participants were asked to rest for one hour. Appetite questionnaires were obtained, and blood samples were collected at 30, 60, 90 and 120 pre-meal, 150, 180, 210, 240 and 300 min post-meal. Metabolic rate was measured every 30 min after each blood sample. Participants were presented to a standard isocaloric PKU type meal at 120 min. After the completion of the last measurement, the participants were presented with an ad libitum buffet test meal.

Other: PKU type meal

Interventions

* Exercise was conducted prior to PKU type meal. * PKU type meal was based on PKU special low protein foods (50% of total energy intake), natural free protein foods (37%) and protein substitute (13%). Calories provided in breakfast were 600 kcal and were not based on individual dietary requirement. 65% of total energy intake was provided from carbohydrate, 13% from protein and 22% from fat.

Exercise trial

PKU type meal was based on PKU special low protein foods (50% of total energy intake), natural free protein foods (37%) and protein substitute (13%). Calories provided in breakfast were 600 kcal and were not based on individual dietary requirement. 65% of total energy intake was provided from carbohydrate, 13% from protein and 22% from fat.

Control trial

Eligibility Criteria

Age22 Years - 35 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsWe decided to study males since in case of females the wash out period of approximately 1 month will be needed to ensure that experimental trials are conducted during the same phase of the menstrual cycle.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men with
  • Body mass index (BMI) ≤29 kg/m2
  • Aged 22-35 years
  • Stable body weight for one month prior to study enrolment, and were
  • Not taking any medication, nutritional supplement or being on a special diet.

You may not qualify if:

  • Smokers
  • Chronic illness
  • Eating disorder
  • History of gastrointestinal operations which could interfere with the results of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univesrity of Glasgow

Glasgow, United Kingdom

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Dalia Malkova, PhD

    University of Glasgow

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

February 4, 2020

First Posted

March 10, 2020

Study Start

June 3, 2018

Primary Completion

June 4, 2019

Study Completion

July 5, 2019

Last Updated

March 10, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations